{"id":"W1977120772","doi":"10.1007/s10741-012-9343-x","title":"Anticoagulation in heart failure: current status and future direction","year":2012,"lang":"en","type":"review","venue":"Heart Failure Reviews","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto; University Health Network","funders":"Bayer HealthCare; Janssen Pharmaceuticals; European Society of Cardiology; National Institute for Health and Care Research","keywords":"Medicine; Rivaroxaban; Internal medicine; Cardiology; Acute coronary syndrome; Apixaban; Heart failure; Stroke (engine); Myocardial infarction; TIMI; Atrial fibrillation; Warfarin; Ejection fraction; Dabigatran; Aspirin; Coronary artery disease; Thrombolysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009770112,0.0005912794,0.00336048,0.0005042659,0.00009218357,0.00006336359,0.000054959,0.0003704516,0.0002690185],"category_scores_gemma":[0.0001007339,0.0004282692,0.0007591812,0.000857793,0.00003847351,0.0002703526,0.00007991396,0.0006009281,0.000465207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001929573,"about_ca_system_score_gemma":0.0001058211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001384456,"about_ca_topic_score_gemma":0.00005055451,"domain_scores_codex":[0.9967298,0.0005449324,0.001318959,0.000551499,0.0003310711,0.0005237235],"domain_scores_gemma":[0.9986405,0.0001072793,0.0004300776,0.000503085,0.00004971934,0.000269333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005631981,0.00001450484,0.0113975,0.0288359,0.00003406361,6.383459e-7,0.00002700449,4.230547e-8,8.187203e-7,0.0001234339,0.01838032,0.9411802],"study_design_scores_gemma":[0.0003665143,0.00003516148,0.004359804,0.01100145,0.001281019,0.00004277891,0.000009669104,0.000001764197,1.631269e-7,0.000006125848,0.9825347,0.0003608676],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001109639,0.9910824,0.00001352942,0.003605353,0.001037823,0.004114726,0.000008146075,0.00006790068,0.00005902925],"genre_scores_gemma":[0.00000916632,0.9914454,0.002530726,0.00007826,0.005171282,0.00006094795,0.0004045269,0.00006511302,0.0002346188],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9641544,"threshold_uncertainty_score":0.9998169,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1225119104505143,"score_gpt":0.4032108914477547,"score_spread":0.2806989809972404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}